Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

OBJECTIVE: To compare the effect of sitagliptin (100 mg) vs glimepiride (1–3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). RESEARCH DESIGN AND METHODS: This 24-week, controlled, open-label study randomized T2DM patients (n = 440...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesavadev, Jothydev, Pillai, Pradeep Babu Sadasivan, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670271/
https://www.ncbi.nlm.nih.gov/pubmed/28982699
http://dx.doi.org/10.1530/EC-17-0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670271/
https://www.ncbi.nlm.nih.gov/pubmed/28982699
http://dx.doi.org/10.1530/EC-17-0100

Ejemplares similares